Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Non-Coding RNA Research|June 9, 2025
CircRNA-based AntimiR therapy: A novel approach to hypertension treatmentVahideh Tarhriz, Kamran Hosseini, Leila Abkhooie, et al.
International Immunopharmacology|July 12, 2024
Effect of Diminazene Aceturate, an ACE2 activator, on platelet CD40L signaling induced glial activation in rat model of hypertensionPriya Tiwari, Mona Elgazzaz, Eric Lazartigues, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 25, 2017
Determining the Enzymatic Activity of Angiotensin-Converting Enzyme 2 (ACE2) in Brain Tissue and Cerebrospinal Fluid Using a Quenched Fluorescent SubstrateSrinivas Sriramula, Kim Brint Pedersen, Huijing Xia, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|January 12, 2026
Microglial Activation and RAS Signaling: A Dual-Edged Sword in NeuroinflammationUma-Priya Priya Mohan, Catalin M Filipeanu, Eric Lazartigues
Cardiovascular Research|September 29, 2011
ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertensionSrinivas Sriramula, Jeffrey P Cardinale, Eric Lazartigues, et al.
The Canadian Journal of Cardiology|June 22, 2023
New Approaches Targeting the Renin-Angiotensin System: Inhibition of Brain Aminopeptidase A, ACE2 Ubiquitination, and AngiotensinogenEric Lazartigues, Catherine Llorens-Cortes, A H Jan Danser
Circulation Research|September 10, 2013
Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertensionHuijing Xia, Srinivas Sriramula, Kavaljit H Chhabra, et al.
Endocrinology|July 12, 2020
Endocrine Significance of SARS-CoV-2's Reliance on ACE2Eric Lazartigues, Mirza Muhammad Fahd Qadir, Franck Mauvais-Jarvis
Hypertension (Dallas, Tex. : 1979)|October 1, 2019
ACE2 and ADAM17 Interaction Regulates the Activity of Presympathetic NeuronsSnigdha Mukerjee, Hong Gao, Jiaxi Xu, et al.
Pageof 10